Is KACL or JNJ a better dividend investment in 2026?

KACL currently yields 16.22% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: KACL offers higher current income.

What is the dividend yield difference between KACL and JNJ?

KACL has a forward dividend yield of 16.22% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 12.86 percentage points.

Home › Compare › KACL vs JNJ

KACL vs JNJ: Dividend Comparison 2026

KACL yields 16.22% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 KACL wins by $37.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

KACL

● Live price

16.22%

Share price

$12.33

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$57.8K

Annual income

$4,399.20

Full KACL calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — KACL vs JNJ

📍 KACL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	KACL	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, KACL + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

KACL pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KACL

Annual income on $10K today (after 15% tax)

$1,378.75/yr

After 10yr DRIP, annual income (after tax)

$3,739.32/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, KACL beats the other by $3,035.71/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KACL + JNJ for your $10,000?

KACL: 50%JNJ: 50%

100% JNJ50/50100% KACL

Portfolio after 10yr

$38.9K

Annual income

$2,613.49/yr

Blended yield

6.72%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KACL

No analyst data

Altman Z

2.1

Piotroski

1/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KACL buys

JNJ buys

No recent congressional trades found for KACL or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricKACLJNJ

Forward yield	16.22% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$57.8K ✓	$20.0K
Annual income after 10y	$4,399.20 ✓	$827.78
Total dividends collected	$29.3K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: KACL vs JNJ ($10,000, DRIP)

Year	KACL Portfolio	KACL Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,322	$1,622.06	$10,676	$355.77	+$1.6K → KACL
2	$15,053	$1,867.96	$11,407	$389.39	+$3.6K → KACL
3	$18,239	$2,132.60	$12,198	$426.53	+$6.0K → KACL
4	$21,931	$2,414.98	$13,056	$467.62	+$8.9K → KACL
5	$26,179	$2,713.82	$13,987	$513.12	+$12.2K → KACL
6	$31,040	$3,027.67	$14,998	$563.56	+$16.0K → KACL
7	$36,567	$3,354.92	$16,098	$619.52	+$20.5K → KACL
8	$42,821	$3,693.81	$17,295	$681.69	+$25.5K → KACL
9	$49,861	$4,042.53	$18,599	$750.82	+$31.3K → KACL
10	$57,750	$4,399.20	$20,022	$827.78	+$37.7K → KACL

KACL vs JNJ: Complete Analysis 2026

KACL — Stock

Kairous Acquisition Corp. Limited focuses on entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on opportunities in Asia excluding China. The company was incorporated in 2021 and is based in Kuala Lumpur, Malaysia.

Full KACL Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this KACL vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KACL vs SCHD KACL vs JEPI KACL vs O KACL vs KO KACL vs MAIN KACL vs ABBV KACL vs MRK KACL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.